BRISTOL MYERS SQUIBB CO BMY revenue by segment, product and geography
In its fiscal year ending 2025-12-31, BRISTOL MYERS SQUIBB CO reported revenue across 27 products and services; the largest, Sales Revenue Gross, was $88.1B (+5.3% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Sales Revenue Gross$88.1Bshare n/a+5.3% yoy
- Net Product Sales$46.8Bshare n/a0.0% yoy
- Growth Brands$26.4Bshare n/a+17.0% yoy
- Legacy Brands$21.8Bshare n/a-15.4% yoy
- Eliquis$14.4Bshare n/a+8.3% yoy
- Opdivo$10Bshare n/a+8.0% yoy
- Orencia$3.71Bshare n/a+0.6% yoy
- Revlimid$2.95Bshare n/a-48.9% yoy
- +19 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$33.3B69.1%-2.4% yoy
- Outside the United States$13.8B28.7%+4.8% yoy
- Other Region$1.09B2.3%+9.1% yoy
Members sum to the consolidated $48.2B for this period.
- Sales Revenue Gross$18.2Bshare n/a-18.0% yoy
- Net Product Sales$12.6Bshare n/a+5.7% yoy
- Growth Brands$7.56Bshare n/a+14.6% yoy
- Legacy Brands$5.42Bshare n/a-4.4% yoy
- Eliquis$4.48Bshare n/a+21.8% yoy
- Opdivo$2.48Bshare n/a-2.9% yoy
- +21 more members in the filing
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.